However, a recent study described the generation of an induced pluripotent stem cell line from an AML patient; this cell line had maintained mutations of XPO1 as well as PALB2, and it showed characteristics similar to embryonic stem cells [60]. This evidence concerns the gene XPO1 and acute myeloid leukemia.